Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis

© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd Background and Aim: Chronic hepatitis C is an important public health problem in Asia. We evaluated the safety, efficacy, and pharmacokinetics of fixed-dose ritonavir-boosted danoprevir plus pegin...

Saved in:

書目詳細資料
Main Authors:	Jia Horng Kao, Shui Yi Tung, Younjae Lee, Satawat Thongsawat, Tawesak Tanwandee, I. Shyan Sheen, Jinzi J. Wu, Hui Li, Barbara J. Brennan, Julian Zhou, Sophie Le Pogam, Isabel Najera, James A. Thommes, George Hill
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85002152541&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56048
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
由: Kao J., et al.
出版: (2017)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: George K.K. Lau, et al.
出版: (2018)

THE DYNAMICS FOR ANTI-HBV INFECTION TREATMENT WITH PEGINTERFERON ALFA-2A
由: VIRA AKMERIANA (NIM: 10108054) ; Pembimbing : Dr. Nuning Nuraini,

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: Lau G.K.K., et al.
出版: (2014)

Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b
由: Sunida Kuakarn, et al.
出版: (2018)

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
由: G. R. Foster, et al.
出版: (2018)

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
由: G. R. Foster, et al.
出版: (2018)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
由: Phunchai Charatcharoenwitthaya, et al.
出版: (2018)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
由: Phunchai Charatcharoenwitthaya, et al.
出版: (2018)

Incidence and Characteristic of Hepatocellular Carcinoma in Hepatitis B Related Cirrhosis
由: Supot Nimanong, et al.
出版: (2020)

Kombinasi interferon alfa-2b dengan ribavirin untuk terapi penderita hepatitis C kronik yang naive
由: Perpustakaan UGM, i-lib
出版: (2006)

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
由: Y. F. Liaw, et al.
出版: (2018)

Molecular Mechanisms of Interferon Resistance Mediated by NS3, NS4A and NS4B Genes of Hepatitis C Viruses in Chronic Hepatitis C Patients Treated with Peginterferon-α and Ribavirin
由: Pattranuch Chusri
出版: (2020)

Efficacy of pegylated interferon and ribavirin for the treatment of chronic hepatitis C, genotype 3 patients in Thailand
由: Watcharasak Chotiyaputta, et al.
出版: (2019)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
由: Charatcharoenwitthaya P., et al.
出版: (2017)

Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
由: Kattareeya Kumthip, et al.
出版: (2018)

Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir
由: Arthitaya Meeprasert, et al.
出版: (2018)

Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir
由: Meeprasert A., et al.
出版: (2017)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
由: Surat Tongyoo, et al.
出版: (2022)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
由: Tongyoo S.
出版: (2023)

Inhibition of dengue virus replication by mycophenolic acid and ribavirin
由: Ratree Takhampunya, et al.
出版: (2018)

Effect of dietary purines on the pharmacokinetics of orally administered ribavirin
由: Li, L., et al.
出版: (2011)

Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis
由: Karjpong Techathuvanan, et al.
出版: (2018)

Nutritional anaemia in cirrhosis of the liver
由: S. Areekul, et al.
出版: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
由: Satawat Thongsawat, et al.
出版: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
由: Satawat Thongsawat, et al.
出版: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
由: Satawat Thongsawat, et al.
出版: (2018)

THE ROLE OF NITRIC OXIDE IN LIVER CIRRHOSIS
由: WEI CHANGLI
出版: (2019)

Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
由: Cozen M.L., et al.
出版: (2019)

Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
由: Thidarath Rattanaburee, et al.
出版: (2018)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
由: Sachiko Seo, et al.
出版: (2018)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
由: Seo, S., et al.
出版: (2016)

Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
由: Kumthip K., et al.
出版: (2017)

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
由: Ahizechukwu C. Eke, et al.
出版: (2020)

Pharmacokinetics of esomeprazole in Thai patients with liver cirrhosis
由: Kanlayanee Archasantisuk
出版: (2006)

Impact of liver cirrhosis on nutritional and immunological status
由: Abhasnee Sobhonslidsuk, et al.
出版: (2018)

Nutritional assessment in various stages of liver cirrhosis
由: Chulaporn Roongpisuthipong, et al.
出版: (2018)

Heterogeneous IgA glomerulonephropathy in liver cirrhosis
由: Sinniah, R.
出版: (2012)

Peptic ulcer in hepatic cirrhosis and renal failure.
由: Kang, J.Y.
出版: (2014)

Primary biliary cirrhosis - An uncommon disease in Singapore
由: Yap, I., et al.
出版: (2016)